307 related articles for article (PubMed ID: 15785425)
21. Recent advances in understanding ion transport mechanisms in polycystic kidney disease.
Sudarikova AV; Vasileva VY; Sultanova RF; Ilatovskaya DV
Clin Sci (Lond); 2021 Nov; 135(21):2521-2540. PubMed ID: 34751394
[TBL] [Abstract][Full Text] [Related]
22. Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis.
Walker RV; Yao Q; Xu H; Maranto A; Swaney KF; Ramachandran S; Li R; Cassina L; Polster BM; Outeda P; Boletta A; Watnick T; Qian F
Nat Commun; 2023 Oct; 14(1):6513. PubMed ID: 37845212
[TBL] [Abstract][Full Text] [Related]
23. Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.
Leonhard WN; Happe H; Peters DJ
J Am Soc Nephrol; 2016 Dec; 27(12):3530-3538. PubMed ID: 27493259
[TBL] [Abstract][Full Text] [Related]
24. Exploring the Spectrum of Kidney Ciliopathies.
Santoni M; Piva F; Cimadamore A; Giulietti M; Battelli N; Montironi R; Cosmai L; Porta C
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33339422
[TBL] [Abstract][Full Text] [Related]
25. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management.
Hanna C; Iliuta IA; Besse W; Mekahli D; Chebib FT
Semin Nephrol; 2023 Jul; 43(4):151434. PubMed ID: 37996359
[TBL] [Abstract][Full Text] [Related]
26. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.
Hartung EA; Guay-Woodford LM
Pediatrics; 2014 Sep; 134(3):e833-45. PubMed ID: 25113295
[TBL] [Abstract][Full Text] [Related]
27. Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges.
McBride L; Wilkinson C; Jesudason S
Int J Womens Health; 2020; 12():409-422. PubMed ID: 32547249
[TBL] [Abstract][Full Text] [Related]
28. Management of Hypertension and Associated Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease.
Rahbari-Oskoui FF
Adv Kidney Dis Health; 2023 Sep; 30(5):417-428. PubMed ID: 38097332
[TBL] [Abstract][Full Text] [Related]
29. The molecular structure and function of fibrocystin, the key gene product implicated in autosomal recessive polycystic kidney disease (ARPKD).
Bannell TAK; Cockburn JJB
Ann Hum Genet; 2024 Jan; 88(1):58-75. PubMed ID: 37905714
[TBL] [Abstract][Full Text] [Related]
30. Hereditary thrombotic thrombocytopenic purpura (TTP) with co-occurring autosomal dominant polycystic kidney disease (ADPKD).
Dahlan R; Bablghaith E
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414344
[TBL] [Abstract][Full Text] [Related]
31. Kidney Measurement and Glomerular Filtration Rate Evolution in Children with Polycystic Kidney Disease.
Stroescu R; Gafencu M; Steflea RM; Chisavu F
Children (Basel); 2024 May; 11(5):. PubMed ID: 38790570
[TBL] [Abstract][Full Text] [Related]
32. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020.
Ars E; Bernis C; Fraga G; Furlano M; Martínez V; Martins J; Ortiz A; Pérez-Gómez MV; Rodríguez-Pérez JC; Sans L; Torra R;
Nefrologia (Engl Ed); 2022; 42(4):367-389. PubMed ID: 36404270
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and outcomes of pediatric autosomal recessive polycystic kidney disease in the Middle East and North Africa.
Salman MA; Elgebaly A; Soliman NA
Pediatr Nephrol; 2024 Jan; ():. PubMed ID: 38261064
[TBL] [Abstract][Full Text] [Related]
34. Liver and kidney disease in ciliopathies.
Gunay-Aygun M
Am J Med Genet C Semin Med Genet; 2009 Nov; 151C(4):296-306. PubMed ID: 19876928
[TBL] [Abstract][Full Text] [Related]
35. Vascular complications in autosomal dominant polycystic kidney disease.
Perrone RD; Malek AM; Watnick T
Nat Rev Nephrol; 2015 Oct; 11(10):589-98. PubMed ID: 26260542
[TBL] [Abstract][Full Text] [Related]
36. Multi-parametric MRI of kidney disease progression for autosomal recessive polycystic kidney disease: mouse model and initial patient results.
MacAskill CJ; Erokwu BO; Markley M; Parsons A; Farr S; Zhang Y; Tran U; Chen Y; Anderson CE; Serai S; Hartung EA; Wessely O; Ma D; Dell KM; Flask CA
Pediatr Res; 2021 Jan; 89(1):157-162. PubMed ID: 32283547
[TBL] [Abstract][Full Text] [Related]
37. Monoallelic Loss-of-Function IFT140 Pathogenic Variants Cause Autosomal Dominant Polycystic Kidney Disease: A Confirmatory Study With Suspicion of an Additional Cardiac Phenotype.
Salhi S; Doreille A; Dancer MS; Boueilh A; Filipozzi P; El Karoui K; Ponce F; Lebre AS; Raymond L; Mesnard L
Am J Kidney Dis; 2024 May; 83(5):688-691. PubMed ID: 37844724
[TBL] [Abstract][Full Text] [Related]
38. Many lessons still to learn about autosomal dominant polycystic kidney disease.
Orr S; Sayer JA
J Rare Dis (Berlin); 2023; 2(1):13. PubMed ID: 37664187
[TBL] [Abstract][Full Text] [Related]
39. The Pathophysiology of Inherited Renal Cystic Diseases.
Satariano M; Ghose S; Raina R
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254980
[TBL] [Abstract][Full Text] [Related]
40. The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.
Seeger-Nukpezah T; Geynisman DM; Nikonova AS; Benzing T; Golemis EA
Nat Rev Nephrol; 2015 Sep; 11(9):515-34. PubMed ID: 25870008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
